Back
Halozyme Therapeutics Stock Predictions

7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.
Buy
66
HALO
Halozyme Therapeutics
Last Price:
$54.51
Seasonality Move:
1.46%
7 Day Trial
ALL ACCESS PASS
$
7

Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.Halozyme Therapeutics Stock Forecast
-
Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 30.5% based on the past 21 years of stock performance.
-
Halozyme Therapeutics has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%
-
Is Halozyme Therapeutics Stock Undervalued?The current Halozyme Therapeutics [HALO] share price is $53.85. The Score for HALO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Halozyme Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 30.5% based on the past 21 years of stock performance.
Halozyme Therapeutics Stock Rating
Buy
66
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics overpriced?
-
Halozyme Therapeutics has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%
Halozyme Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
halozyme.com
52-Week Data
52-Week High:
70.51
52-Week Low:
42.01
Prediction Charts
Market Cap:
6.6B
Price in USD:
53.85
Volume:
1.4M
Beta:
1.42
Technical Analysis
SMA50:
57.81
SMA100:
58.44
SMA200:
56.21
52-Wk Change:
7.87%
Stock Predictions
-
Is Halozyme Therapeutics stock public?Yes, Halozyme Therapeutics is a publicly traded company.
-
What is the Halozyme Therapeutics stock quote today?The Halozyme Therapeutics stock price is 53.85 USD today.
-
How to buy Halozyme Therapeutics stock online?You can buy Halozyme Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-22 | 53.64 | 53.75 | 54.19 | 53.04 |
May-23 | 53.23 | 54.54 | 54.68 | 53.03 |
May-27 | 55.25 | 54.42 | 55.25 | 53.76 |
May-28 | 54.50 | 54.43 | 55.09 | 54.22 |
May-29 | 54.69 | 54.73 | 54.96 | 54.00 |
May-30 | 54.75 | 56.07 | 56.39 | 54.26 |
Jun-2 | 55.69 | 55.64 | 56.32 | 54.49 |
Jun-3 | 55.58 | 53.31 | 55.58 | 52.73 |
Jun-4 | 53.01 | 53.85 | 54.11 | 53.01 |
Jun-5 | 53.66 | 53.55 | 54.24 | 53.21 |
Jun-6 | 54.15 | 54.25 | 54.76 | 53.44 |
Jun-9 | 54.50 | 54.38 | 54.95 | 54.00 |
Jun-10 | 54.28 | 53.77 | 54.51 | 53.54 |
Jun-11 | 53.77 | 53.85 | 55.60 | 53.74 |
Halozyme Therapeutics Earnings
Halozyme Therapeutics Earnings Report: Per Share Halozyme Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Halozyme Therapeutics Forecast Revenue Growth
Halozyme Therapeutics Stock Analysis: Historical quarterly revenues per share for Halozyme Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.06 per share, an increase this year of $1.19 per share, and an increase next year of $1.27 per share.
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.